To understand the effect of therapeutic doses of laser application on the neurosensory retina, detailed histologic1-3 and optical coherence tomographic (OCT)4-10 evaluations have been used in both animal models and the human eye. We sought to evaluate photoreceptor structure associated with laser photocoagulation lesions using 2 high-resolution retinal imaging tools: adaptive optics (AO) and spectral-domain OCT (SD-OCT).
Two patients received short-duration (20-millisecond) Pascal laser therapy (532 nm; OptiMedica Corp) for clinical indications. Subject 1 was a 57-year-old woman with macular edema from hemicentral retinal vein occlusion. Treatment consisted of 3 × 3 grid laser applications with a 100-μm spot diameter and 100-μm spacing using 100 mW of power and a 20-millisecond duration to produce barely visible lesions clinically. Subject 2 was a 43-year-old woman with proliferative diabetic retinopathy treated with panretinal laser photocoagulation consisting of 4 × 4 grid arrays with a 200-μm spot diameter and 200-μm spacing using 425 mW of power and a 20-millisecond duration to produce lesions of moderate intensity (eFigure 1). For calibration of all retinal images, axial length was measured using an IOLMaster (Carl Zeiss Meditec). The Pascal system delivered evenly spaced laser applications with clinical precision, facilitating our investigation in these patients. Institutional review board approval was obtained.
Volumetric SD-OCT images of the macula were obtained using SD-OCT (Bioptigen, Inc) and Cirrus high-definition OCT (Carl Zeiss Meditec). Volumes were nominally 6 × 6 mm and consisted of 128 B-scans (512 A-scans per B-scan). Cirrus software version 5.0 was used to create C-scans (en face reconstructions) from the macular volumes to aid in coregistration with other images.
Images of the photoreceptor mosaic were obtained using an AO flood-illuminated camera11 and/or an AO scanning ophthalmoscope (AOSO).12 Rod and cone densities were estimated using a semiautomated direct counting procedure.13 Lesion size was estimated manually as the edge-to-edge distance of the disruption of the photoreceptor mosaic (AO) or the disruption of the photoreceptor layers (SD-OCT).
The AO imaging was successful after edema regressed. The correlation between B-scan and C-scan SD-OCT images, color fundus photographs, and an AOSO montage of the photoreceptors in the area of macular grid laser treatment was determined (Figure 1A-D and Figure 2). On AOSO, circular zones of hyporeflectivity with uniform absence of photoreceptors corresponded to laser lesions observed by SD-OCT and color fundus photographs. Photoreceptor disturbances appeared to correspond to the area of laser application and not beyond it.
The mean (SD) size of 20 lesions on AOSO was 92.0 (10.9) μm, with substantial variability in their appearance (eFigure 2). In an area between 2 lesions, we observed an undisturbed photoreceptor mosaic of 82 819 rods/mm2 and 8658 cones/mm2. Both of these values are consistent with normal values from the same system.12 The areas absent of photoreceptors corresponded in size to the areas of photocoagulation, indicating that photoreceptor cell migration into the laser lesion was limited or absent.
The SD-OCT images of representative panretinal laser photocoagulation lesions and surrounding areas are shown in Figure 1E and F. The AO images of the photoreceptor mosaic and lesion are shown in Figure 3. Lesions consisted of circular areas of central hyperreflectivity surrounded by a ring of hyporeflectivity (Figure 3B), corresponding to the central hyperpigmented areas and surrounding concentric rings of hypopigmentation, respectively (Figure 3A). Diffusely high reflectivity was observed at the margins of some of the lesions (Figure 3D and F). The cone mosaic appeared normal immediately adjacent to the lesion (Figure 3E and F). The cone density at a nearby location was 8732 cones/mm2, consistent with normal values for this eccentricity (Figure 3C). The approximate mean (SD) diameter of the panretinal laser photocoagulation lesions was 306 (43.2) μm (5 lesions evaluated), with precise measurements limited by somewhat ill-defined lesion borders. While cones (and sometimes the smaller rods) can be visualized in Figure 3C, E, and F, the hyperreflective spots in Figure 3B are likely not photoreceptors, illustrating a challenge in interpreting AO-derived images of the cone mosaic.
Using high-resolution retinal imaging, we evaluated the tissue response in the human eye to grid and focal laser treatment applied to achieve clinically accepted end points using the Pascal laser system. We detected no evidence of reduced photoreceptor density around the laser lesions, no apparent size reduction of the lesions relative to the initial application diameters, and thus no direct evidence of photoreceptor migration or healing. Reestablishment of the photoreceptor layer in areas of retinal photocoagulation has been observed in rabbit eyes subjected to Pascal laser lesions of barely visible to moderate intensity.10 We suspect that observed differences in photoreceptor healing relative to experimental studies may relate to differences among species, degree of pigmentation, cellular maturity, and variability in the grading of lesion intensities.
We are unaware of previously published reports of laser photocoagulation lesions in the living human eye evaluated using AO imaging. Furthermore, the discrimination between rods and cones, with each cell type having its own characteristic size and distribution elucidated by confocal AOSO,12 is a unique aspect of this study that distinguishes it from other in vivo studies. The ability of AO imaging to directly assess photoreceptor structure with cellular resolution may facilitate new approaches to laser therapy, perhaps with the intent of preserving more photoreceptors.
Correspondence: Dr Han, Department of Ophthalmology, Medical College of Wisconsin, 925 N 87th St, Milwaukee, WI 53226 (dhan@mcw.edu).
Author Contributions: Dr Han had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Financial Disclosure: None reported.
Funding/Support: This work was supported by grants P30EY001931, T32EY014537, and R01EY017607 from the National Institutes of Health, an unrestricted departmental grant from Research to Prevent Blindness, the Thomas M. Aaberg Sr Retina Research Fund, and the Jack A. and Elaine D. Klieger Professorship in Ophthalmology (Dr Han). Mr Croskrey is the recipient of a Career Development Award from Research to Prevent Blindness. Temporary use of the Pascal laser was provided by OptiMedica Corp. This investigation was conducted in a facility constructed with support from grant C06 RR-RR016511 from the Research Facilities Improvement Program, National Center for Research Resources, National Institutes of Health.
Additional Contributions: Alfredo Dubra, PhD, designed the AOSO and Phyllis Summerfelt provided technical/administrative assistance in figure preparation.
1.Smiddy WE, Fine SL, Quigley HA, Hohman RM, Addicks EA. Comparison of krypton and argon laser photocoagulation: results of stimulated clinical treatment of primate retina.
Arch Ophthalmol. 1984;102(7):1086-10926204628
PubMedGoogle ScholarCrossref 2.Smiddy WE, Fine SL, Green WR, Glaser BM. Clinicopathologic correlation of krypton red, argon blue-green, and argon green laser photocoagulation in the human fundus.
Retina. 1984;4(1):15-216539496
PubMedGoogle ScholarCrossref 3.Marshall J, Bird AC. A comparative histopathological study of argon and krypton laser irradiations of the human retina.
Br J Ophthalmol. 1979;63(10):657-668574395
PubMedGoogle ScholarCrossref 4.Toth CA, Birngruber R, Boppart SA,
et al. Argon laser retinal lesions evaluated in vivo by optical coherence tomography.
Am J Ophthalmol. 1997;123(2):188-1989186124
PubMedGoogle Scholar 5.Framme C, Walter A, Prahs P,
et al. Structural changes of the retina after conventional laser photocoagulation and selective retina treatment (SRT) in spectral domain OCT.
Curr Eye Res. 2009;34(7):568-57919899970
PubMedGoogle ScholarCrossref 6.Kriechbaum K, Bolz M, Deak GG, Prager S, Scholda C, Schmidt-Erfurth U. High-resolution imaging of the human retina in vivo after scatter photocoagulation treatment using a semiautomated laser system.
Ophthalmology. 2010;117(3):545-55120031226
PubMedGoogle ScholarCrossref 8.Muqit MM, Gray JC, Marcellino GR,
et al. Fundus autofluorescence and Fourier-domain optical coherence tomography imaging of 10 and 20 millisecond Pascal retinal photocoagulation treatment.
Br J Ophthalmol. 2009;93(4):518-52519074915
PubMedGoogle ScholarCrossref 9.Muqit MM, Gray JC, Marcellino GR,
et al. In vivo laser-tissue interactions and healing responses from 20- vs 100-millisecond pulse Pascal photocoagulation burns.
Arch Ophthalmol. 2010;128(4):448-45520385940
PubMedGoogle ScholarCrossref 10.Paulus YM, Jain A, Gariano RF,
et al. Healing of retinal photocoagulation lesions.
Invest Ophthalmol Vis Sci. 2008;49(12):5540-554518757510
PubMedGoogle ScholarCrossref 11.Rha J, Schroeder B, Godara P, Carroll J. Variable optical activation of human cone photoreceptors visualized using a short coherence light source.
Opt Lett. 2009;34(24):3782-378420016612
PubMedGoogle ScholarCrossref 12.Dubra A, Sulai Y, Norris JL,
et al. Noninvasive imaging of the human rod photoreceptor mosaic using a confocal adaptive optics scanning ophthalmoscope.
Biomed Opt Express. 2011;2(7):1864-187621750765
PubMedGoogle ScholarCrossref 13.Li KY, Roorda A. Automated identification of cone photoreceptors in adaptive optics retinal images.
J Opt Soc Am A Opt Image Sci Vis. 2007;24(5):1358-136317429481
PubMedGoogle ScholarCrossref